Several other equities research analysts have also commented on JYNT. B. Riley lowered Joint from a buy rating to a neutral rating in a research report on Friday, May 6th. Roth Capital lowered their price objective on Joint from $75.00 to $40.00 in a research report on Monday, May 9th. Lake Street Capital reduced their target price on Joint from $100.00 to $50.00 in a research note on Friday, May 6th. Craig Hallum downgraded Joint from a buy rating to a hold rating and reduced their target price for the stock from $90.00 to $30.00 in a research note on Friday, May 6th. Finally, DA Davidson downgraded Joint from a neutral rating to an underperform rating and reduced their target price for the stock from $69.00 to $13.00 in a research note on Monday, May 9th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of Hold and a consensus price target of $33.33.
Joint Price Performance
Shares of NASDAQ JYNT opened at $21.52 on Wednesday. The business’s 50 day moving average price is $15.76 and its 200 day moving average price is $29.14. The firm has a market cap of $311.18 million, a P/E ratio of 143.48 and a beta of 1.33. Joint has a 52 week low of $13.10 and a 52 week high of $111.06. The company has a quick ratio of 1.25, a current ratio of 1.25 and a debt-to-equity ratio of 0.07.
Insider Activity at Joint
In other news, major shareholder Bandera Partners Llc acquired 22,187 shares of Joint stock in a transaction that occurred on Tuesday, May 24th. The stock was purchased at an average cost of $14.98 per share, with a total value of $332,361.26. Following the purchase, the insider now owns 2,105,075 shares in the company, valued at $31,534,023.50. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In the last ninety days, insiders bought 214,269 shares of company stock valued at $3,378,580. 3.50% of the stock is owned by insiders.
Institutional Trading of Joint
Several large investors have recently added to or reduced their stakes in the stock. Pinebridge Investments L.P. purchased a new position in shares of Joint during the 4th quarter worth $33,000. Point72 Hong Kong Ltd purchased a new position in shares of Joint during the 4th quarter worth $36,000. Cullen Frost Bankers Inc. purchased a new position in shares of Joint during the 1st quarter worth $71,000. Alpha Paradigm Partners LLC purchased a new position in shares of Joint during the 4th quarter worth $215,000. Finally, ProShare Advisors LLC grew its holdings in shares of Joint by 61.9% during the 4th quarter. ProShare Advisors LLC now owns 3,472 shares of the company’s stock worth $228,000 after purchasing an additional 1,328 shares during the period. 86.39% of the stock is currently owned by hedge funds and other institutional investors.
Joint Company Profile
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States.
- Get a free copy of the StockNews.com research report on Joint (JYNT)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.